John B. Sanfilippo & Son, Inc. - Common Stock (JBSS)

John B. Sanfilippo & Son (NASDAQ:JBSS) reported record fiscal 2026 net sales of $1.2 billion and a 4.6% increase in diluted earnings per share, although fourth-quarter profitability declined as higher costs, recall-related expenses and customer charges pressured margins. For the fiscal fourth q

John B Sanfilippo & Son (NASDAQ:JBSS) reported fourth-quarter financial results on Thursday. The transcript from the company's fourth-quarter earnings call has been provided below. This transcript is brought to

JBSS Q1 2026 Earnings Transcript

These three consumer staples companies are overlooked, but they are quietly building wealth with resilient business models.

John B. Sanfilippo & Son, Inc. (NASDAQ: JBSS), a prominent player in the nut and snack industry, is undergoing a significant strategic transformation, shifting its core identity from a primarily commercial ingredient supplier to a robust, consumer-focused packaged foods enterprise. This calculated pivot, characterized by a heightened emphasis on its private

John B Sanfilippo & Son just reported results for the fourth quarter of 2024.

John B Sanfilippo & Son just reported results for the third quarter of 2024.

Companies Reporting Before The Bell • ATRenew (NYSE:RERE) is estimated to report quarterly earnings at $0.06 per share on revenue of $397.98 million.

John B. Sanfilippo & Son, Inc., through its subsidiary, JBSS Ventures, LLC, processes and distributes tree nuts and peanuts in the United States.

Companies Reporting Before The Bell • Novartis (NYSE:NVS) is likely to report quarterly earnings at $1.68 per share on revenue of $11.56 billion.

Although US stocks closed lower on Friday, there were a few notable insider trades.

With US stock futures trading slightly higher this morning on Monday, some of the stocks that may grab investor focus today are as follows:

  Companies Reporting Before The Bell • CNFinance Hldgs (NYSE:CNF) is estimated to report quarterly earnings at $0.03 per share on revenue of $69.74 million.

Companies Reporting Before The Bell • Novo Nordisk (NYSE:NVO) is expected to report quarterly earnings at $0.85 per share on revenue of $6.84 billion.